Pfizer Inc.
Toll-like receptor agonists

Last updated:

Abstract:

The present invention relates to imidazo-pyridinyl compounds, or a pharmaceutically acceptable salt thereof, to pharmaceutical compositions comprising such compounds and salts, and to methods of using such compounds, salts and compositions for the treatment of abnormal cell growth, including cancer, in a subject.

Status:
Grant
Type:

Utility

Filling date:

13 Jul 2020

Issue date:

24 May 2022